This course has expired. View available courses.

Neurology

The Role of Early DMTs and the Impact of COVID-19 on MS

Multiple Sclerosis (MS) is a chronic autoimmune disorder for which there is currently no cure. Management of MS during the COVID-19 pandemic created challenges for patients in the Kingdom and around the World. In this webinar, our panel of international experts will review the current COVID-19 protection and vaccine recommendations for patients with MS and NMOSD. Panelists will also discuss the updates on treatment management and new evidence with MS and NMOSD disease modifying therapies and how this will influence practice today and in the near future.


This activity is supported by an independent educational grant from Roche Products Saudi Arabia.

DURATION

1 hr

PROFESSION

Physician, Nursing, Pharmacy, Allied Health, Medical Resident, Student, Specialist

# OF CREDITS

1

ACCREDITATION

MOC - Section 1

EXPIRY DATE

2023-03-09

Multiple Sclerosis (MS) is a chronic autoimmune disorder for which there is currently no cure. Management of MS during the COVID-19 pandemic created challenges for patients in the Kingdom and around the World. In this webinar, our panel of international experts will review the current COVID-19 protection and vaccine recommendations for patients with MS and NMOSD. Panelists will also discuss the updates on treatment management and new evidence with MS and NMOSD disease modifying therapies and how this will influence practice today and in the near future.


This activity is supported by an independent educational grant from Roche Products Saudi Arabia.

Faculty

Mohammed Al Jumah, MBBS, MD, FRCPC

Yaser Al Malik, MD, FRCPC, ABPN, CSCN

Amani Alshehri, B Pharm, PharmD, BCPS, RPh, PGY2

Anthony Traboulsee, MD, FRCP

Learning objectives

Upon completion of this continuing education program, participants will be better able to:

  • Develop treatment goals for patient with multiple sclerosis (MS)
  • Discuss the considerations and benefits of early disease modifying treatment for patients with MS
  • Review current recommendations for the management of Neuromyelitis optica spectrum disorders (NMOSD)
  • Provide an overview of COVID-19 impact on the delivery of MS care
  • Describe COVID-19 severity for patients with MS
  • Review the current COVID-19 protection and vaccine recommendations for patients with MS

Accreditation

This webinar is a live Accredited Learning Activity (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada, and is approved by Queens University for up to 1.0 CPD hour(s).
Cost of course:  
Free
# of credits: 1
Duration: 1 hr

FAQs & HELP

MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.

All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.

The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

No, registration with MDBriefCase is free!

To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.

If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.

Please note: if you submitted multiple password resets, only the link on the most recent email is valid.

You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.